Head-to-head comparison of anterior nares and nasopharyngeal swabs for SARS-CoV-2 antigen detection in a community drive-through test centre in the UK

被引:0
|
作者
Byrne, Rachel L. [1 ]
Aljayyoussi, Ghaith [1 ]
Kontogianni, Konstantina [1 ]
Clerkin, Karina [1 ]
Mcintyre, Mathew [1 ]
Wardale, Jahanara [1 ]
Williams, Christopher T. [1 ]
Body, Richard [2 ]
Adams, Emily R. [3 ,4 ]
de Vos, Margaretha [5 ]
Escadafal, Camille [5 ]
Atienzar, Ana I. Cubas [1 ]
机构
[1] Univ Liverpool Liverpool Sch Trop Med, Ctr Drugs & Diagnost, Liverpool, England
[2] Manchester Univ NHS Fdn Trust, Manchester, England
[3] Global Access Diagnost GADx, Thurleigh, England
[4] Univ Oxford, Nuffield Dept Med, Oxford, England
[5] FIND, Geneva, Switzerland
关键词
COVID-19;
D O I
10.1136/bmjresp-2023-001747
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective To conduct a head-to-head diagnostic accuracy evaluation of anterior nares (AN) and nasopharyngeal (NP) swabs for SARS-CoV-2 antigen detection using two brands of rapid diagnostic tests (Ag-RDT).Methods Two prospective diagnostic evaluations were carried out at different time points and participant cohorts to evaluate the performance of paired AN and NP swabs in two Ag-RDT brands: Sure-Status (PMC, India) and Biocredit (RapiGEN, South Korea). The sensitivity and specificity of AN and NP swabs for each of the index test cohorts were calculated against the reverse transcription quantitative PCR (RT-qPCR) TaqPath COVID-19 (ThermoFisher, UK) using NP swabs as reference standard.Results A total of 372 participants were recruited for the Sure-Status cohort and 232 for the Biocredit, of which 119 (32.1%) and 122 (53.7%) were SARS-CoV-2 positive by RT-qPCR, respectively. Sensitivity and specificity of AN swabs were equivalent to those obtained with NP swabs in both cohorts: 83.9% (95% CI 76.0-90.0) and 98.8% (95% CI 96.6-9.8) using NP swabs and 85.6% (95% CI 77.1-91.4) and 99.2% (95% CI 97.1-99.9) with AN swabs for Sure-Status and; 81.2% (95% CI 73.1-87.7) and 99.0% (95% CI 94.7-86.5) with NP swabs and 79.5% (95% CI 71.3-86.3) and 100% (95% CI 96.5-100) with AN swabs for Biocredit. The agreement of the AN and NP swabs was high for both brands with an inter-rater reliability (kappa) of 0.918 and 0.833 for Sure-Status and Biocredit, respectively. The overall 50% limits of detection (LoD50) and 95% LoD (LoD95) were 0.9-2.4x104 and 3.0-3.2x108 RNA copies/mL for NP swabs and 0.3-1.1x105 and 0.7-7.9x107 RNA copies/mL for AN swabs, with no significant difference in LoD for any of the swab types or test brands.Conclusions The diagnostic accuracy of the two SARS-CoV-2 Ag-RDT brands evaluated in this study was equivalent using AN swabs than NP swabs. However, test line intensity was lower when using AN swabs, which could negatively influence the interpretation of the Ag-RDT results by lay users.Trail registration number NCT04408170.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
    Perkmann, Thomas
    Perkmann-Nagele, Nicole
    Koller, Thomas
    Mucher, Patrick
    Radakovics, Astrid
    Marculescu, Rodrig
    Wolzt, Michael
    Wagner, Oswald F.
    Binder, Christoph J.
    Haslacher, Helmuth
    MICROBIOLOGY SPECTRUM, 2021, 9 (01): : 1 - 11
  • [42] Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens
    Hogan, Catherine A.
    Garamani, Natasha
    Lee, Andrew S.
    Tung, Jack K.
    Sahoo, Malaya K.
    Huang, ChunHong
    Stevens, Bryan
    Zehnder, James
    Pinsky, Benjamin A.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)
  • [43] Comparison between the Sofia SARS Antigen FIA Test and the PCR Test in Detection of SARS-CoV-2 Infection
    Cernila, Manca
    Logar, Mateja
    Mozina, Hugon
    Osredkar, Josko
    LABORATORY MEDICINE, 2023, 54 (02) : E44 - E48
  • [44] The National SARS-CoV-2 Serology Assay Evaluation Group. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison (vol 20, pg 1390, 2020)
    Ainsworth, M.
    LANCET INFECTIOUS DISEASES, 2020, 20 (12): : E298 - E298
  • [45] Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR
    Hirotsu, Yosuke
    Maejima, Makoto
    Shibusawa, Masahiro
    Amemiya, Kenji
    Nagakubo, Yuki
    Hosaka, Kazuhiro
    Sueki, Hitomi
    Hayakawa, Miyoko
    Mochizuki, Hitoshi
    Tsutsui, Toshiharu
    Kakizaki, Yumiko
    Miyashita, Yoshihiro
    Omata, Masao
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 7 - 14
  • [46] High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection
    Courtellemont, L.
    Guinard, J.
    Guillaume, C.
    Giache, S.
    Rzepecki, V.
    Seve, A.
    Gubavu, C.
    Baud, K.
    Le Helloco, C.
    Cassuto, G. N.
    Pialoux, G.
    Hocqueloux, L.
    Prazuck, T.
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (05) : 3152 - 3157
  • [47] Comparison of saliva with oral and nasopharyngeal swabs for SARS-CoV-2 detection on various commercial and laboratory-developed assays
    Labbe, Annie-Claude
    Benoit, Patrick
    Gobeille Pare, Sarah
    Coutlee, Francois
    Levesque, Simon
    Bestman-Smith, Julie
    Dumaresq, Jeannot
    Lavallee, Christian
    Houle, Claudia
    Martin, Philippe
    Mak, Anton
    Gervais, Philippe
    Langevin, Stephanie
    Jacob-Wagner, Marieve
    Gagnon, Simon
    St-Hilaire, Manon
    Lussier, Nathalie
    Yechouron, Ariane
    Roy, David
    Roger, Michel
    Fafard, Judith
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (09) : 5333 - 5338
  • [48] Comparison of Unsupervised Home Self-collected Midnasal Swabs With Clinician-Collected Nasopharyngeal Swabs for Detection of SARS-CoV-2 Infection
    McCulloch, Denise J.
    Kim, Ashley E.
    Wilcox, Naomi C.
    Logue, Jennifer K.
    Greninger, Alex L.
    Englund, Janet A.
    Chu, Helen Y.
    JAMA NETWORK OPEN, 2020, 3 (07)
  • [49] Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously
    Wang, Xiong
    Tan, Li
    Wang, Xu
    Liu, Weiyong
    Lu, Yanjun
    Cheng, Liming
    Sun, Ziyong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 94 : 107 - 109
  • [50] Performance of an automated chemiluminescent immunoassay for SARS-COV-2 IgM and head-to-head comparison of Abbott and Roche COVID-19 antibody assays
    Lau, C. S.
    Hoo, S. P.
    Liang, Y. L.
    Phua, S. K.
    Aw, T. C.
    PRACTICAL LABORATORY MEDICINE, 2021, 25